ASML’s, Monopoly

ASML’s Monopoly Stretch: Record Revenue Guidance Meets Capacity Constraints and China Headwinds

Published on 07/21/2026 at 14:31 | Redaktion boerse-global.de

ASML raises 2026 revenue outlook to €43-45B on AI-driven chip demand, with order book sold out through 2027, but geopolitical pressures cut China revenue share and stock lags.

ASML Lifts 2026 Revenue Forecast to €45B on AI Chip Demand, Faces China Risks
ASML’s Monopoly Stretch: Record Revenue Guidance Meets Capacity Constraints and China Headwinds Illustration mit AI erstellt übermittelt durch boerse-global.de

The Dutch lithography giant ASML has sharply lifted its 2026 revenue forecast to between €43 billion and €45 billion, up from an earlier range of €36 billion to €40 billion, after posting a blockbuster second quarter that saw net sales jump to €9.3 billion from €7.7 billion a year earlier. Net profit for the period ended June 28 reached €2.9 billion, while gross margin came in at 54 percent — ahead of the company’s own projection. For the third quarter, management guided for revenue of €11 billion to €12 billion, signaling that the momentum is far from fading.

The raised outlook reflects an order book that is essentially sold out through 2027, according to the company, driven by artificial intelligence investments that are fuelling demand for both advanced logic and memory chips. ASML is the sole supplier of extreme ultraviolet and high-NA lithography systems, a monopoly that allows it to command prices of around €400 million per high-NA machine. To keep pace, the company plans to boost production capacity for EUV and DUV systems by 30 percent in 2027 and by another 30 percent in 2028. JPMorgan analysts believe annual output could eventually reach 110 units, well above the current ceiling of about 90 without expansion.

Yet the buoyant order book and upgraded forecasts sit uneasily alongside mounting geopolitical pressures. ASML now expects China to account for roughly 20 percent of its 2026 revenue, down from more than 40 percent previously, as export restrictions — including potential impact from the MATCH Act — tighten their grip. A recent study by the Hague Centre for Strategic Studies, commissioned by the Dutch government, flagged a "very high risk" of Chinese influence in the domestic semiconductor sector, citing years of espionage targeting ASML and NXP, and called for stricter security checks at the company’s Veldhoven headquarters.

Should investors sell immediately? Or is it worth buying Asml?

To retain talent in an intensely competitive labor market, ASML is dangling a conditional share grant worth €20,000 per employee for those who remain through 2030. The grant takes effect on January 1, 2027, with a vesting period ending January 1, 2030. The company employs roughly 44,500 to 45,000 people worldwide, more than half based in the Netherlands. The move comes even as ASML announced in January the elimination of about 1,700 positions in the Netherlands and the U.S., a sign that cost discipline remains in play even as it invests heavily in capacity.

Investors, however, have not fully rewarded the narrative. The stock recently traded at €1,554.80, up 1.78 percent on the day, but still 11 percent below its 52-week high of €1,748 — and down 9.6 percent over the past 30 days. The broader semiconductor sell-off, triggered in part by the market’s reaction to Chinese AI model Kimi K3, has weighed on even a fundamental standout like ASML. Valuation remains a battleground: at a trailing price-to-earnings ratio of roughly 54.9, the stock trades at a premium to the sector average of 45.8 but below a comparison group of competitors at 66.3. Some analysts see the shares as 17 percent undervalued based on a fair P/E of 71.1, while skeptics argue they could be as much as 52 percent overpriced.

Analyst targets vary widely. Bernstein sets a price target of $2,623, Barclays €2,400, and Susquehanna €2,350, while the average target among eight analysts surveyed is around $2,421 — most of whom rate the stock a buy. A potential wild card is Elon Musk’s planned Terafab facility in Texas, which could become a new revenue source for ASML down the road. For now, the company’s path toward a trillion-dollar market capitalization hinges on how deftly it navigates the China question and whether chipmakers’ appetite for its machines can sustain the current trajectory.

Ad

Asml Stock: New Analysis - 21 July

Fresh Asml information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Asml analysis...

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | NL0010273215 | ASML’S | boerse | 69822090 |